Straumann invests in V2R

Montréal, Québec, October 27th 2016 – Straumann (Straumann Holding AG – SWX: STMN), global leader in implant, restorative and regenerative dentistry, today announced acquiring a stake in V2R Biomedical. The strategic partnership will leverage V2R’s guided surgery planning expertise as Straumann cements its position as the premier tooth replacement solutions provider.

V2R is enthusiastic about this opportunity to grow internationally alongside Straumann, with whom it already shares a commitment to responsible innovation, to the benefit of patients and clinicians.

Straumann’s media release is available on the company’s corporate website.